Suburban Behavioral Health Services
1S443 Summit Avenue, 201, Oakbrook Terrace
4.8(470 Google reviews)
United States
1 listed treatment center serving Oak Lawn and the surrounding area.
1S443 Summit Avenue, 201, Oakbrook Terrace
4.8(470 Google reviews)
Every dose is given in a certified healthcare setting, followed by at least two hours of monitoring. Arrange transportation home after each visit. Distances below are straight-line miles from Oak Lawn.
10.2 miles away · Willowbrook
11.2 miles away · Hinsdale
211 West Chicago Avenue, Suite 216A, Hinsdale
5.0(22 Google reviews)
11.3 miles away · Orland Park
12 miles away · Oak Park
1100 Lake Street, 260, Oak Park
5.0(22 Google reviews)
12 miles away · Chicago
12.4 miles away · Westmont
1 Oak Hill Drive, 100, Westmont
4.5(146 Google reviews)
For people in Oak Lawn considering SPRAVATO®, costs depend on insurance benefits, the treatment setting, and how services are billed. Both the medication and the visit for administration and observed monitoring may generate charges. Ask for an estimate covering both—not just the nasal spray—and remember that an estimate is not a guarantee of coverage.
Prior authorization is common. Your insurer may request records of earlier antidepressant trials, including which medicines you took and how you responded. Ask the treatment center which records it needs, who submits the authorization request, and whether approval is required before scheduling. If coverage is denied, ask about the reason and any available review or appeal process.
Medicare coverage may involve Part B or Part D, depending on the plan and treatment setting. Illinois Medicaid coverage also depends on the plan and setting. Neither program guarantees payment at every center. Confirm benefits with your insurer and verify that the center accepts your specific coverage.
Manufacturer savings programs exist for some eligible commercially insured patients, but not for people using government insurance. Eligibility rules apply; ask what assistance, if any, applies to your circumstances and which charges it addresses.
Before starting, ask the center and insurer:
Getting these answers early can help you plan without assuming a particular out-of-pocket cost.
SPRAVATO® treatment takes place only in a healthcare setting certified through the Spravato REMS safety program. You self-administer the nasal spray under a healthcare provider’s direct observation; it is never sent home with you. Before booking, confirm the location’s current REMS certification and whether it is accepting new patients.
For treatment-resistant depression, the typical labeled schedule starts with twice-weekly visits during weeks 1–4, followed by weekly visits during weeks 5–8. Maintenance may be weekly or every two weeks. Your prescriber determines your schedule; do not assume these intervals will be your personal treatment plan.
Plan for at least two hours of monitoring after each dose, plus time for check-in and other care. A visit can therefore take longer than two hours. When arranging time off work, allow for the full appointment and transportation rather than treating it like a quick prescription pickup.
You need someone else to drive you home. You must not drive or operate machinery until the next day after a restful sleep. Arrange a dependable ride for every appointment, consider a backup driver, and ask the center about its discharge and transportation requirements before relying on a ride service.
If you cannot find a listed, available center in Oak Lawn, expand your search to listed locations in Orland Park, Chicago, Oakbrook Terrace, Naperville, or Aurora. A directory listing alone does not establish REMS certification or appointment availability. Call to confirm both, along with insurance acceptance, before committing to travel. Choose a location you can realistically reach repeatedly, not just for an initial consultation.
When searching for SPRAVATO® near Oak Lawn, use directory listings as a starting point, then ask the treatment location to confirm its current REMS certification. A listing does not by itself verify certification. If local appointments are unavailable, consider listed locations in Orland Park, Chicago, Oakbrook Terrace, Naperville, or Aurora. Confirm appointment availability and insurance acceptance before arranging a consultation.
Spravato is FDA-approved for adults with treatment-resistant depression, either alone or with an oral antidepressant. It is also approved for depressive symptoms in adults with major depressive disorder with acute suicidal thoughts or behavior, together with an oral antidepressant. It is not approved for children. A clinician must review your symptoms, treatment history, and health risks to determine whether it is appropriate; a diagnosis alone does not guarantee eligibility.
Coverage depends on your plan and the treatment setting. Prior authorization and records of previous antidepressant trials are commonly needed. Ask whether both the medication and the observed monitoring visit are covered, whether the center is in network, and what you may owe. Medicare and Illinois Medicaid may cover treatment depending on the plan and setting, but you should confirm benefits and the center’s acceptance before starting.
You give yourself the nasal spray under a healthcare provider’s direct observation in a REMS-certified setting. Staff monitor you for at least two hours after the dose, including for sedation, dissociation, breathing problems, and increased blood pressure. The full appointment may take longer. You cannot take the medicine home, and you need someone else to drive you home afterward.
Spravato can cause sedation, dissociation—a sense of disconnection from yourself or your surroundings—breathing problems, and increased blood pressure. Its boxed warnings also address abuse and misuse and suicidal thoughts and behaviors. It is a Schedule III controlled substance. Discuss your health history and medicines with the prescriber, and tell staff promptly about symptoms during monitoring. Do not drive or operate machinery until the next day after a restful sleep.
No. Spravato has not been shown to prevent suicide or reduce suicidal thoughts or behavior, and it does not replace hospitalization when needed. Its approval for depressive symptoms in adults with major depressive disorder with acute suicidal thoughts or behavior requires use with an oral antidepressant. If you are in crisis, call or text 988. If there is immediate danger or a medical emergency, call 911 rather than waiting for a treatment appointment.
Approved uses, nearby treatment centers, and medically sourced patient guides.